Product equivalence study comparing the tolerability, pharmacokinetics, and pharmacodynamics of various human immunoglobulin-G formulations.

Andresen, I; Kovarik, J M; Spycher, M; Bolli, R

Andresen, I; Kovarik, J M; Spycher, M; Bolli, R.

Affiliation

Andresen I; ZLB Central Laboratory, Blood Transfusion Service, Swiss Red Cross, Bern, Switzerland.

J Clin Pharmacol ; 40(7): 722-30, 2000 Jul.

Article in En | MEDLINE | ID: mdl-10883413

Subject(s)

Immunoglobulin G/pharmacology; Immunoglobulins, Intravenous/pharmacology; Adolescent; Adult; Chemistry, Pharmaceutical; Double-Blind Method; Excipients/analysis; Female; Hepatitis B Antibodies/administration & dosage; Hepatitis B Antibodies/pharmacology; Humans; Immunity/drug effects; Immunoglobulin G/administration & dosage; Immunoglobulin G/adverse effects; Immunoglobulin G/metabolism; Immunoglobulins, Intravenous/administration & dosage; Immunoglobulins, Intravenous/adverse effects; Immunoglobulins, Intravenous/metabolism; Infusions, Intravenous; Isoleucine/blood; Isoleucine/urine; Leukocyte Count/drug effects; Male; Niacinamide/blood; Niacinamide/urine; Proline/blood; Proline/urine; Tumor Necrosis Factor-alpha/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Immunoglobulins, Intravenous Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Clin Pharmacol Year: 2000 Document type: Article Affiliation country: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links